Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
5.65
0.00 (0.00%)
At close: Nov 26, 2025, 1:00 PM EST
5.63
-0.02 (-0.35%)
Pre-market: Nov 28, 2025, 6:16 AM EST
Evaxion Employees
Evaxion had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.
Employees
46
Change (1Y)
-3
Growth (1Y)
-6.12%
Revenue / Employee
$166,304
Profits / Employee
-$117,783
Market Cap
46.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | 35 | -1 | -2.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVAX News
- 15 days ago - Evaxion announce 2026 financial calendar - GlobeNewsWire
- 20 days ago - Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 - GlobeNewsWire
- 21 days ago - Evaxion A/S (EVAX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Evaxion announces business update and third quarter 2025 financial results - GlobeNewsWire
- 24 days ago - Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate - GlobeNewsWire
- 27 days ago - Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 - GlobeNewsWire
- 4 weeks ago - Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 - GlobeNewsWire
- 4 weeks ago - Evaxion raises $7.2 million, extending cash runway to second half of 2027 - GlobeNewsWire